Skip to main content
Explore URMC

Wilmot Cancer Institute Logo


Patrick M. Reagan, M.D.


Clinical Interests

Hematologic Oncology; Leukemia, Myeloma, Blood & Marrow Transplant; Lymphoma, Chronic Lymphocytic Leukemia

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Fax: (585) 273-1042

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments


I chose this specialty because I had an interest in lymphoid malignancies throughout my training, and I am excited to be part of a field that is moving rapidly toward targeted treatments. This translates into more options that are effective and well-tolerated for patients.

In addition, I strongly believe in the enrollment of patients in well-designed clinical trials in both the upfront and relapsed settings. Clinical trials enable our lymphoma program to remain on the cutting edge of clinical care. My areas of expertise include the treatment of older patients with lymphoid malignancies, as well as clinical trial development in this population.

Conditions I Treat:

- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Chronic lymphocytic leukemia



  • Hematology - American Board of Internal Medicine
  • Internal Medicine - American Board of Internal Medicine


BS | St. Lawrence University

MD | SUNY Upstate Medical University

Post-doctoral Training & Residency

07/01/2013 - 06/30/2015
Fellowship in Hematology/Oncology at University of Rochester Medical Center

07/01/2012 - 07/01/2013
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2010 - 07/01/2012
Residency in Internal Medicine at University of Virginia Children's Hospital

07/01/2009 - 7/1/2010
Internship in Internal Medicine at University of Virginia Children's Hospital

VIEW ALL expand_more


Lymphoma Research Foundation Clinical Research Mentoring Program

American Society of Hematology Clinical Research Training Institute

John and Carol Bennett Travel Fellowship Award
Sponsor: John and Carol Bennett
Location: Wilmot Cancer Institute

Alpha Omega Alpha, Upstate Medical University
Sponsor: Upstate Medical University

Phi Beta Kappa, St. Lawrence University
Sponsor: St. Lawrence University

Academic All American, Football, St. Lawrence University
Sponsor: St. Lawrence University

Beta Beta Beta, Biological Honor Society, St. Lawrence University
Sponsor: St. Lawrence University

VIEW ALL expand_more


Journal Articles

Neelapu SS, Locke FL, Bartlett NL, Lekakis LJ, Miklos DB, Jacobson CA, Braunschweig I, Oluwole OO, Siddiqi T, Lin Y, Timmerman JM, Stiff PJ, Friedberg JW, Flinn IW, Goy A, Hill BT, Smith MR, Deol A, Farooq U, McSweeney P, Munoz J, Avivi I, Castro JE, Westin JR, Chavez JC, Ghobadi A, Komanduri KV, Levy R, Jacobsen ED, Witzig TE, Reagan P, Bot A, Rossi J, Navale L, Jiang Y, Aycock J, Elias M, Chang D, Wiezorek J, Go WY. "Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma." The New England journal of medicine.. 2017 Dec 28; 377(26):2531-2544. Epub 2017 Dec 10.

Reagan PM, Davies A. "Current treatment of double hit and double expressor lymphoma." Hematology. 2017 Dec 8; 2017(1):295-297.

Reagan PM, Friedberg JW. "Reassessment of Anti-CD20 Therapy in Lymphoid Malignancies: Impact, Limitations, and New Directions." Oncology.. 2017 May 15; 31(5):402-11.